References
- Norris FH, Calanchini PR, Fallat R, Panchri S, Jewett BJ. The administration of guanidine in amyotrophic lateral sclerosis. Neurology 1979; 24: 721–728.
- Hillel AD, Miller RM, Yorkston K, McDonald E, Norris FH, Konikow N. Amyotrophic lateral sclerosis severity scale. Neuroepidemiology 1989; 8: 142–150.
- Appel V, Stewart SS, Smith G, Appel SH. A rating scale for amyotrophic lateral sclerosis: description and preliminary experience. Ann Neurol 1987; 22: 328–333.
- ALS CNTF Treatment Study (ACTS) Phase I–II Study Group. The pharmacokinetics of subcutaneously administered recombinant human ciliary neurotrophic factor (RHCNTF) in patients with amyotrophic lateral sclerosis – Relation to parameters of the acute-phase response. Clin Neuropharma- col 1995; 18: 500–514.
- Andres PL, Hedlund W, Finison L, Conlon T, Felmus M, Munsat TL. Quantative motor assessment in amyotrophic lateral sclerosis. Neurology 1986; 36: 937–941.